Today: 8 February 2026
Subscribe

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck shares rose 2.2% to $118.33 in after-hours trading Wednesday after new data showed its experimental cholesterol drug enlicitide cut LDL by up to 60% in a major trial. The company’s 2026 revenue forecast of $65.5–$67.0 billion missed Wall Street estimates, citing pressure from off-patent drugs and U.S. pricing. Keytruda sales reached $8.37 billion last quarter, while Gardasil revenue fell 34%.
5 February 2026
···
Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking Holdings shares fell 0.8% to $4,607.13 in after-hours trading Wednesday after Citizens Bank downgraded the stock, citing AI risks and a lack of near-term growth drivers. The stock has dropped 9.3% since Tuesday amid heavy volume and sector-wide declines. Booking will report fourth-quarter and full-year earnings on Feb. 18. KeyBanc maintained an overweight rating but trimmed its price target.
5 February 2026
··
Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase shares fell 6.2% to $168.62 in after-hours trading Wednesday after Nevada’s gaming regulator filed a civil enforcement action to block the company’s sports-linked event contracts. The Nevada Gaming Control Board seeks a court order halting what it calls unlicensed wagering. Coinbase called the move a “state power grab,” arguing federal law should apply. Bitcoin and ether also dropped, weighing on exchange stocks.
5 February 2026
···
Snowflake stock drops again: insider sale filing and AI jitters pressure SNOW shares

Snowflake stock drops again: insider sale filing and AI jitters pressure SNOW shares

Snowflake shares fell 4.6% to $165.29 Wednesday, extending a 13% slide since Monday. Product EVP Christian Kleinerman sold 10,000 shares at $197.09 each, a filing showed. The company closed its acquisition of Observe and announced new AI tools at its Build London event. Investors await Feb. 25 earnings for signs of demand and AI adoption.
5 February 2026
···
S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global shares fell 0.6% to $465.51 Wednesday, extending a two-day drop to nearly 12% amid concerns over AI’s impact on data firms. Trading volume was four times the 20-day average. The company’s Mobility division will rebrand as Mobility Global ahead of a planned spin-off, pending board approval. S&P Global reports earnings Feb. 10.
5 February 2026
···
Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco shares fell 2.3% to $81.16 in after-hours trading Wednesday, following a broader tech sell-off that pushed the Nasdaq down 1.51%. The company will report fiscal Q2 earnings on Feb. 11 and recently announced NBC Sports will use its AI networking tech for the 2026 Winter Olympics. Cisco also launched an AI-powered security tool and promoted its AI strategy at a summit with Nvidia.
5 February 2026
··
AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie shares fell 3.9% in after-hours trading Wednesday after quarterly results showed Rinvoq sales missed expectations at $2.37 billion. Skyrizi sales beat forecasts at $5.01 billion, while Humira revenue dropped 25.9% to $1.25 billion. The company projected 2026 adjusted earnings above estimates, but investors focused on challenges replacing Humira as biosimilar competition grows.
5 February 2026
···
IREN stock plunges 17% as bitcoin slides again, setting up a tense earnings read

IREN stock plunges 17% as bitcoin slides again, setting up a tense earnings read

IREN shares fell 17.4% to $44.94 in heavy after-hours trading Wednesday, tracking a 3.3% drop in bitcoin. Volume reached 66.2 million shares. A Jane Street filing disclosed a 4.7% stake in IREN days ahead of its earnings report, due after the bell Thursday. Other U.S.-listed bitcoin miners also declined.
5 February 2026
········
Caterpillar stock slips from highs as insider sales and split analyst calls hit CAT shares

Caterpillar stock slips from highs as insider sales and split analyst calls hit CAT shares

Caterpillar shares fell 1.6% to $691.82 Wednesday before rising 0.4% after hours. SEC filings showed group presidents Anthony Fassino and Denise Johnson exercised options and sold shares on Feb. 2. Analysts split on outlook, with Truist raising its price target to $786 and Morgan Stanley holding an underweight rating. Trading volume hit 4.8 million as shares swung between $675 and $723.11.
5 February 2026
·
Intuit stock price rebounds nearly 3% after AI fears hit software — what’s next for INTU

Intuit stock price rebounds nearly 3% after AI fears hit software — what’s next for INTU

Intuit shares rose 2.7% to $445.64 Wednesday, recovering some losses after an 11% drop Tuesday amid AI-driven fears that hit software stocks. Volume nearly tripled to 7 million shares. The S&P 500 software and services index continued to fall, with the sector losing about $830 billion in value since Jan. 28. Investors await Intuit’s Q2 results on Feb. 26.
5 February 2026
···
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
Lam Research stock (LRCX) sinks after-hours as chip selloff deepens; COO change in focus

Lam Research stock (LRCX) sinks after-hours as chip selloff deepens; COO change in focus

Lam Research shares fell 8.8% to $209.78 in after-hours trading Wednesday, deepening a rout in chip stocks as the PHLX semiconductor index dropped 4.4%. The company confirmed COO Pat Lord will retire in March, with Sesha Varadarajan named as successor. Lam also added Cadence CEO Anirudh Devgan to its board. U.S.-China chip tensions and a weak AMD forecast weighed on the sector.
5 February 2026
·
1 … 56 57 58 59 60 … 1,643

Stock Market Today

Adobe stock (ADBE) slips into the weekend — what traders watch before Monday

Adobe stock (ADBE) slips into the weekend — what traders watch before Monday

8 February 2026
Adobe shares closed down 0.4% at $268.38 Friday, trailing a broader tech rally that sent the Dow above 50,000 for the first time. Semrush shareholders approved a merger with Adobe, advancing the $1.9 billion deal. Investors await key U.S. jobs and inflation data this week. Adobe’s next earnings report is expected in mid-March.
Snowflake stock snaps back with 7% jump — what to watch before Monday

Snowflake stock snaps back with 7% jump — what to watch before Monday

8 February 2026
Snowflake shares jumped 7.5% to $168.43 Friday, tracking a late-week tech rebound. Director Michael L. Speiser sold 50,741 shares on Feb. 6 under a pre-set plan, according to a regulatory filing. The company recently announced a $200 million partnership with OpenAI. Snowflake reports earnings Feb. 25.
Go toTop